Clinical Trial Update: DT PACE, Tandem Autologous Transplant, Maintenance Therapy for Waldenstrom's Macroglobulinemia Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating DT-PACE with tandem autologous transplant and maintenance therapy for Waldenström macroglobulinemia. The study was terminated an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Waldenström Macroglobulinemia

Drugs mentioned

• DT-PACE regimen

Snippet

Sponsor: University of Arkansas | Conditions: Waldenstrom Macroglobulinemia | Phase 2 | Status: TERMINATED | Results posted: 2011-07-15